[80] The trial reported cumulative occurrence of major adverse cardiovascular events, a primary end-point event of the trial, for 569 of the 8803 patients in the semaglutide group, which were 6.5% of the participants, and for 701 of the 8801 patients in the placebo group, which were 8% of the participants, showing relative 18.8% less major adverse cardiovascular events, such as death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, occurring for participants who had received semaglutide in the trial relative to those who had received placebo over the course of around 48 months, or 34.213.7 months, which was the mean (SD) total duration of the participants in either group's exposure to the placebo or semaglutide during the trial
CVS Caremark manages prescription benefits for more than 25-30 million Americans ( 4 ), meaning this formulary change could directly affect tens of millions of people
Before starting Ozempic, we encourage consultations with our qualified providers to review your medical history and health status
Once reconstituted: 28-day BUD typical for bacteriostatic water reconstitution (preservative-containing) 14-day BUD typical for sterile water reconstitution (preservative-free) Dont shake
The efficacy and safety of semaglutide were evaluated in eight global randomized controlled clinical trials involving 8,800 patients with type 2 diabetes